If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
59.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (3.509%)
Market Cap: £48.05m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Level of acceptances

9 Jun 2008 18:23

RNS Number : 3283W
Mentor Graphics Corporation
09 June 2008
Β 

ο»Ώ

Not for release, publication or distribution, in whole or in part, in, into or from the United States, Canada, Australia or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

ANNOUNCEMENT

FOR IMMEDIATE RELEASE

9Β JuneΒ 2008

CASHΒ OFFERΒ FORΒ FLOMERICSΒ GROUP PLCΒ ("FLOMERICS" OR THE "COMPANY") BYΒ MENTOR GRAPHICS CORPORATIONΒ ("MENTOR")

Β 

FIRST CLOSING DATE ACCEPTANCE LEVEL AND EXTENSION OF OFFER

SummaryΒ 

The Board ofΒ MentorΒ announces the level of acceptances for its Offer forΒ FlomericsΒ at the first closing date of the OfferΒ andΒ the extension of its Offer untilΒ 23Β JuneΒ 2008.Β 

First closing date of the Offer - acceptancesΒ 

As atΒ 3.00 pm onΒ 9 June 2008, the first closing date of the Offer, valid acceptances had been received in respect ofΒ 560,769Β FlomericsΒ Shares representing approximatelyΒ 2.44Β per cent ofΒ Flomerics'Β existing issued share capital. Each of these acceptances may be counted byΒ MentorΒ towards the satisfaction of the acceptance condition of the Offer.Β MentorΒ currently holdsΒ 6,821,715Β Flomerics SharesΒ representing approximately 29.74Β perΒ cent. of Flomerics' existing issued share capital.

Offer extendedΒ 

The Offer, which remains subject to the terms and conditions set out in the Offer Document, is being extended and will remain open for acceptance until the next closing date, which will beΒ 3.00 pm onΒ 23Β JuneΒ 2008. Any further extension of the Offer will be publicly announced by 8.00am on the business day following the day on which the Offer is otherwise due to expire, or such later time or date as the Panel may agree.Β 

Flomerics Shareholders who want to accept the Offer should complete the Form of Acceptance and send this together with their share certificates toΒ Computershare Investor Services plc, Corporate Actions Projects, The Pavilions, BridgwaterΒ Road, Bristol BS99 6AH, so as to be received as soon as possible and, inΒ any event, by no later than 3.00 pm onΒ 23Β JuneΒ 2008.Β Flomerics ShareholdersΒ who hold their shares in uncertificated form should ensure that an electronic acceptance is made through CREST as set out in the Offer Document.Β 

Enquiries:

Mentor

Dennis Weldon

RyersonΒ Schwark Tel: +1 503 685 7000

CenkosΒ SecuritiesΒ plcΒ 

Nicholas WellsΒ  Tel: +44Β 20Β 7397 8900

Bell Pottinger Corporate & Financial

David Rydell

Olly Scott Tel: +44Β 20 7861 3232

Cenkos, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively forΒ MentorΒ andΒ no one else in connection with the Offer and will not be responsible to anyone other thanΒ MentorΒ for providing the protections afforded to its customers or for providing advice in relation to the Offer or in relation to the contents of this announcement or any transaction or arrangement referred to herein.

Canaccord,Β which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively forΒ MentorΒ andΒ no one else in connection with the Offer and will not be responsible to anyone other thanΒ MentorΒ for providing the protections afforded to its customers or for providing advice in relation to the Offer or in relation to the contents of this announcement or any transaction or arrangement referred to herein.

This announcement is not intended to and does not constitute, or form any part of, an offer or an invitation to purchase, subscribe for or otherwise acquire, sell or dispose ofΒ any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Offer or otherwise.Β Β The OfferΒ isΒ made solely through the Offer Document and the Form of Acceptance, which together contain the full terms and conditions of the Offer, including details of how to accept the Offer.Β Β Any acceptance or other response to the Offer should be made only on the basis of the information contained in the Offer Document and the Form of Acceptance.Β Β The laws of relevant jurisdictions may affect the availability of the Offer to persons not resident in the United Kingdom.Β Β Persons who are not resident in the United Kingdom, or who are subject to the laws of any jurisdiction other than the United Kingdom, should inform themselves about and observe any applicable legal and regulatory requirements.Β Β The Offer DocumentΒ isΒ available for public inspectionΒ at the offices of Cenkos.Β 

The OfferΒ isΒ not beingΒ made, directly or indirectly, in or into the United States or by use of mails of, or any means or instrumentality (including, without limitation, facsimile transmission, telephoneΒ or internet) of inter-state or foreign commerce of, or any facilities ofΒ a national, stateΒ or other securities exchange ofΒ the United States, norΒ isΒ it beingΒ made directlyΒ or indirectly in or into CanadaΒ orΒ Australia and the OfferΒ isΒ not capable of acceptance by any such use, means, instrumentality orΒ facilitiesΒ or from within the United States, Canada orΒ Australia or any other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction.Β Β Accordingly, copies of this announcement are not being, will not be and must not be mailed or otherwise forwarded, distributed or sent in, into orΒ from the United States, Canada orΒ Australia or any other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction and persons receiving this announcement (including without limitation custodians, nominees and trustees) must not mail,Β or otherwiseΒ forward, distribute or send it in, into or from the United States, CanadaΒ orΒ Australia or anyΒ other such jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction.

Cautionary statement regarding forward-looking statements

ThisΒ announcement may contain forward-looking statements concerningΒ Mentor.Β Β Generally the words 'will', 'may',Β 'should', 'continue', 'believes', 'expects', 'intends', 'anticipates' or similarΒ expressions identify forward-looking statements.Β Β The forward-looking statementsΒ involve risks and uncertainties that could cause actual results to differΒ materially from those suggested by them.Β Β Many of these risks and uncertaintiesΒ relate to factors that are beyondΒ Mentor'sΒ abilities to control orΒ estimate precisely, such as future market conditions and the behaviours of otherΒ market participants, and therefore undue reliance should not be placed on suchΒ statements which speak only as at the date of thisΒ announcement.Β Β MentorΒ assumesΒ no obligation and doesΒ not intend to update theseΒ forward-looking statements, except as required pursuant to applicable law.

Dealing disclosure requirements

Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the 'City Code'), if any person is, or becomes, 'interested' (directly or indirectly) in one per cent. or more of any class of 'relevant securities' ofΒ Flomerics, all 'dealings' in any 'relevant securities' ofΒ FlomericsΒ (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30Β pm (London time) on the London BusinessΒ Day following the date of the relevant transaction.Β Β This requirement will continue until the date on which the Offer becomes, or is declared, unconditional as to acceptance, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends.Β Β If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' ofΒ FlomericsΒ they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the City Code, all 'dealings' in 'relevant securities' ofΒ FlomericsΒ byΒ MentorΒ orΒ FlomericsΒ or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London BusinessΒ Day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk.

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities.Β Β In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referencedΒ to, securities.

Terms in quotation marks are defined in the City Code, which can also be found on the Panel's website.Β Β If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
OUPFLMRTMMTMBTP
Date   Source Headline
19th Jun 202612:52 pmRNS2026 Annual General Meeting - Result of voting
4th Jun 20267:00 amRNSAcquisition of Helipebs Controls Ltd
28th May 20267:00 amRNS2025 Annual Report Posting & Notice of AGM
8th May 20262:28 pmRNSHolding(s) in Company
7th Apr 20267:00 amRNSAnnual Financial Report
24th Mar 20267:00 amRNSAudited Preliminary FY25 Results & Outlook update
18th Mar 20267:00 amRNSNotice of Annual results and presentation
12th Feb 20264:22 pmRNSCompletion of Acquisition
10th Feb 20264:36 pmRNSHolding(s) in Company
9th Feb 20265:25 pmRNSHolding(s) in Company
9th Feb 20264:28 pmRNSDirector/PDMR Shareholding
6th Feb 202612:08 pmRNSResult of General Meeting
22nd Jan 20264:12 pmRNSHolding(s) in Company (Correction)
22nd Jan 20262:36 pmRNSResult of Retail Offer
22nd Jan 202612:56 pmRNSHolding(s) in Company
22nd Jan 202612:48 pmRNSHolding(s) in Company
21st Jan 20262:44 pmRNSPublication of Circular
20th Jan 20263:26 pmRNSResult of Placing and Notice of General Meeting
20th Jan 20267:02 amRNSProposed Retail Offer
20th Jan 20267:01 amRNSProposed Placing And Retail Offer
20th Jan 20267:00 amRNSFull Year Trading Update & Acquisition
1st Oct 202510:39 amRNSChange of Auditor
9th Sep 20257:00 amRNSHalf-Year Report - six months ended 30 June 2025
4th Sep 20258:00 amRNSHalf-Year results - webcast presentations
29th Jul 20257:00 amRNSGroup Trading Update & Notice of Interim Results
22nd Jul 20257:00 amRNS-RNew Contract wins & Partnerships
18th Jun 20258:00 amRNS-RFlowtech wins Waterside City bridge contract
17th Jun 20252:26 pmRNSResult of AGM
27th May 20255:13 pmRNSCorrection re: timing of the 2025 AGM on 17 June
22nd May 20257:00 amRNSAvailability - FY24 Annual Report & Notice of AGM
21st May 202510:30 amRNS-RFlowtech capitalises on acquisitions opportunities
11th Apr 20257:00 amRNSDirector/PDMR Shareholding
9th Apr 20257:00 amRNSPreliminary results - year ended 31 December 2024
4th Apr 20251:19 pmRNSNotice of Results and webcast presentations
12th Feb 202511:00 amRNSDirector/PDMR Shareholding
30th Jan 20257:00 amRNSFULL YEAR TRADING UPDATE
23rd Dec 20241:53 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSPDMR - Director share dealing
26th Sep 20247:00 amRNS2024 Half-year Report & Trading update
18th Sep 20247:00 amRNSAppt of Joint Broker & Notice of Half-year results
27th Aug 20247:00 amRNSAcquisition of Thomas Wright/Thorite Group Ltd
31st Jul 20247:00 amRNSHolding(s) in Company
30th Jul 20247:00 amRNSGroup Trading Update & Notice of Interim Results
1st Jul 20247:00 amRNSChange of Adviser
19th Jun 20245:46 pmRNSHolding(s) in Company
18th Jun 20245:42 pmRNSIssue of shares to the Employees Benefit Trust
11th Jun 202412:17 pmRNSResult of AGM
31st May 202412:19 pmRNSHolding(s) in Company
22nd May 20246:03 pmRNSHolding(s) in Company
22nd May 20247:00 amRNSExercise of Warrant, Issue of new shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.